Paracoccidioidomycosis: Cells expressing IL17 and Foxp3 in cutaneous and mucosal lesions

Microbial Pathogenesis

Volumn 50, Issue 5, 2011, Pages 263-267

  Pagliari, Carla ^a   Fernandes, Elaine Raniero ^a   Stegun, Felipe Weisshaupt ^a   da Silva, Wellington Luiz F ^a   Seixas Duarte, Maria Irma ^a   Sotto, Mirian N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immunopathology; Mucosa; Paracoccidioidomycosis; Skin; Th17

Indexed keywords

INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3;

ANTIFUNGAL ACTIVITY; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; MOUTH INFECTION; MOUTH MUCOSA; MUCOSA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE STUDY; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; SKIN INFECTION; SOUTH AMERICAN BLASTOMYCOSIS;

BIOPSY; FORKHEAD TRANSCRIPTION FACTORS; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-17; LYMPHOCYTES; MUCOUS MEMBRANE; PARACOCCIDIOIDOMYCOSIS; SKIN;

EID: 79953061391     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.12.008     Document Type: Article

References (44)

1. Marques S.A. Cutaneous lesions. Paracoccidioidomycosis 1994, 259-269. CRC Press, Boca Raton. M.F. Franco, C.S. Lacaz, A. Restrepo, G. Del Negro (Eds.).
2. Musatti C.C., Reskallah M.T., Mendes E., Mendes N.F. In vivo and in vitro evaluation of cell-mediated immunity in patients with paracoccidioidomycosis. Cell Immunol 1976, 24:365-378.
3. Cano L.E., Kashino S.S., Arruda C., André D., Xidieh C.F., Singer-Vermes L.M., et al. Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect Immun 1998, 66:800-806.
4. Benard G., Romano C.C., Cacere C.R., Juvenale M., Mendes-Giannini M.J.S., Duarte A.J.S. Imbalance of Il2, IFN-γ and IL10 secretion in the immunosupression associated with human paracoccidioidomycosis. Cytokine 2000, 13:248-252.
5. Diniz S.N., Cisalpino P.S., Freire A.T., Silva-Teixeira D.N., Contigli C., Rodrigues Júnior V., et al. In vitro granuloma formation, NO production and cytokines profile from human mononuclear cells induced by fractionated antigens of Paracoccidioides brasiliensis. Hum Immunol 2001, 62:799-808.
6. Mello L.M., Silva-Vergara M.L., Rodrigues V. Patients with active infection with paracoccidioides brasiliensis present a Th2 immune response characterized by high interleukin-4 and interleukin-5 production. Hum Pathol 2001, 63:149-154.
7. Pagliari C., Sotto M.N. Dendritic cells and pattern of cytokines in paracoccidioidomycosis skin lesions. Am J Dermatopathol 2003, 25:107-112.
8. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
9. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
10. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
11. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007, 8:639-646.
12. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL17 and Th17 cells. Ann Rev Immunol 2009, 27:485-517.
13. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004, 190:624-631.
14. Kleinschek M.A., Muller U., Brodie S.J., Stenzel W., Kohler G., Blumenschein W.M., et al. IL23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL12. J Immunol 2006, 176:1098-1106.
15. Rudner X.L., Happel K.I., Young E.A., Shellito J.E. Interleukin-23 (IL23)-IL17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007, 75:3055-3061.
16. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006, 441:235-238.
17. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-β induces development of the Th17 lineage. Nature 2006, 441:231-234.
18. Basso A.S., Cheroutre H., Mucida D. More stories on Th17 cells. Cell Res 2009, 19:399-411.
19. Cavassani K.A., Campanelli A.P., Moreira A.P., Vancim J.O., Vitali L.H., Mamede R.C., et al. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J Immunol 2006, 177:5811-5818.
20. Netea M.G., Sutmuller R., Hermann C., Van der Graaf C.A., Van der Meer J.W., Van Krieken J.H., et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL10 and regulatory T cells. J Immunol 2004, 172:3712-3718.
21. Romani L., Puccetti P. Protective tolerance to fungi: the role of IL10 and tryptophan catabolism. Trends Microbiol 2006, 14:183-189.
22. Hohl T.M., Rivera A., Pamer E.G. Immunity to fungi. Curr Opin Immunol 2006, 18:465-472.
23. Khader A.S., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL23 and IL17 in the establishment of protective pulmonary CD4(+) T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
24. Forsthuber T.G., Ji N. Quo vadis Th1 and Th2 cells in autoimmunity and infectious diseases: Th17 cells, the new kid on the block. Expert Rev Clin Immunol 2007, 3:251-254.
25. Zelante T., De Luca A., D'Angelo C., Moretti S., Romani L. IL17/Th17 in anti-fungal immunity: what's new?. Eur J Immunol 2009, 99:634-675.
26. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 10:2696-2706.
27. Loures F.V., Pina A., Felonato M., Calich V.L.G. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009, 183:1279-1290.
28. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., Jolicoeur F.C., He Y., Zhang M., et al. IL-17 stimulates the production and expression of proinflammatory cytokines.IL1-β and TNF-α by human macrophages. J Immunol 1998, 160:3513-3521.
29. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
30. Ji Y., Yiwei C., Xue Y., Di G., Lubing Z., Xinrong Y., et al. Th17 and Natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1472-1483.
31. Gonzales A., Lenzi H.L., Motta E.M., Caputo L., Sahaza J.H., Cock A.M., et al. Expression of adhesion molecules in lungs of mice infected with Paracoccidioides brasiliensis conidia. Microbes Infect 2005, 7:666-673.
32. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 2009, 27:551-589.
33. Rouse B.T., Suvas S. Regulatory T cells and immunity to pathogens. Expert Opin Biol Ther 2007, 7:1-9.
34. Mills K.H. Regulatory T cells: friend or foe in immunity to infection?. Nat Rev Immunol 2004, 4:841-855.
35. Rouse B.T., Sarangi P.P., Suvas S. Regulatory T cells in virus infections. Immunol Rev 2006, 212:272-286.
36. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001, 194:1395-1406.
37. Loures F.V., Pina A., Felonato M., Araujo E.F., Leite K.R.M., Calich V.L.G. Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect Immunol 2010, 78:1078-1088.
38. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
39. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor t-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10:1-7.
40. Wohlfert E., Belkaid Y. Plasticity of Treg at infected sites. Mucosal Immunol 2010.
41. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., Sacks D.L. CD4 + CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
42. Kursar M., Koch M., Mittrucker H.W., Nouailles G., Bonhagen K., Kamradt T., et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007, 178:2661-2665.
43. Gondek D.C., Lu L.F., Quezada S.A., Sakagushi S., Noelle R.J. Cutting edge: contact-mediated suppression by CD4 + CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005, 174:1783-1786.
44. Pagliari C., Pereira N.V., Kanashiro L., Stegun F.W., Croda J., Duarte M.I., et al. Characterization of cytotoxic immune response in skin and mucosal lesions of paracoccidioidomycosis. J Cutan Pathol 2010, 37:565-570.